Press Releases Orgenesis Inc.

Equities

ORGS

US68619K2042

Delayed Nasdaq Other stock markets 11:07:47 14/05/2024 pm IST			5-day change	1st Jan Change
0.63 ^USD	+3.45%		+18.82%	+25.82%

16/04	North American Morning Briefing : Powell Comments, -2-	DJ
15/04	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orgenesis Provides Year End Business Update	16/04	AQ
Orgenesis : Non-Reliance on Previously Issued Financial Report - Form 8-K	16/04	PU
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	10/04	AQ
Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference	18/03	AQ
Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes	13/03	AQ
Orgenesis Inc. Announces $2.3 Million Private Placement	04/03	AQ
Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing	29/02	AQ
Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic	31/01	AQ
Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM	14/11	AQ
Orgenesis Provides Business Update for the Third Quarter of 2023	14/11	AQ
Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering	08/11	AQ
Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding	02/11	AQ
Orgenesis Announces Withdrawal of Proposed Public Offering	31/23/31	AQ
Orgenesis Announces Proposed Underwritten Public Offering	31/23/31	AQ
CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States	21/23/21	AQ
Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support	06/23/06	AQ
Orgenesis Provides Business Update for Second Quarter of 2023	11/23/11	AQ
Orgenesis Schedules Second Quarter 2023 Business Update Conference Call	10/23/10	AQ
Orgenesis Appoints Finance Veteran Elliot Maltz as its Chief Financial Officer	13/23/13	AQ
Orgenesis Announces Name Change of Morgenesis Business Unit to Octomera	11/23/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Orgenesis Inc.

Equities

ORGS

US68619K2042

Press Releases

Filters